Linfeng Xu
321 Zhongshan Road
Nanjing, 210008, China
Nanjing, 210008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Autologous Vas Deferens Sling for Early Urinary Continence During Retzius-Sparing Robot-Assisted Radical Prostatectomy: A Randomized Controlled Clinical Trial.
Journal: Healthcare (Basel, Switzerland)
Published: March 29, 2026
Olaparib combined with abiraterone in HRR-mutated metastatic hormone-sensitive prostate cancer: a single-arm phase II trial.
Journal: World journal of urology
Published: December 21, 2025
Modified water vapor thermal therapy for large-volume benign prostatic hyperplasia.
Journal: BMC urology
Published: November 11, 2025
Neoadjuvant pamiparib plus abiraterone and androgen deprivation therapy for high-risk/very high-risk localized prostate cancer: an open-label, single-arm, phase 2 study.
Journal: Prostate cancer and prostatic diseases
Published: August 09, 2025
DECIPHER-PRAD: an advanced fragmentomics-based cell-free DNA assay for prostate cancer early detection.
Journal: Cell communication and signaling : CCS
Published: July 23, 2025
Feasibility and safety assessment of the AGIBOT® robotic system in urological surgery: preliminary results from a multicenter study.
Journal: Surgical endoscopy
Published: May 03, 2025
Recovery of urinary continence after neoadjuvant hormonal therapy plus radical prostatectomy: A multicenter retro-prospective cohort study with propensity score matching.
Journal: Asian journal of urology
Published: February 10, 2025
Identification of the metabolic protein ATP5MF as a potential therapeutic target of TNBC.
Journal: Journal of translational medicine
Published: June 25, 2024
Neoadjuvant darolutamide plus androgen deprivation therapy for high-risk and locally advanced prostate cancer: a multicenter, open-label, single-arm, phase II trial.
Journal: World journal of urology
Published: June 02, 2024
Modified Retzius-sparing robot-assisted radical prostatectomy for cases with anterior tumor: a propensity score-matched analysis.
Journal: World journal of urology
Published: May 09, 2023
Androgen deprivation therapy plus abiraterone or docetaxel as neoadjuvant therapy for very-high-risk prostate cancer: a pooled analysis of two phase II trials.
Journal: Frontiers in pharmacology
Published: May 05, 2023
Robot-assisted Simple Enucleation Versus Standard Robot-assisted Partial Nephrectomy for Low- or Intermediate-complexity, Clinical T1 Renal Tumors: A Randomized Controlled Noninferiority Trial.
Journal: European urology oncology
Published: March 16, 2023
Last Updated: 09/26/2026